New drug FT1 tested for safety in healthy volunteers
NCT ID NCT06610487
First seen Mar 07, 2026 · Last updated May 11, 2026 · Updated 7 times
Summary
This early-stage study tested the safety of a new drug called FT1 in 60 healthy adults aged 18 to 45. Participants received one or more injections of FT1 or a placebo to see if it causes any side effects. The study also looked at how the drug moves through the body and whether it triggers an immune response. Since it only involved healthy volunteers, it did not test if FT1 treats any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIARRHEA CAUSED BY DRUG (DISORDER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bishan Hospital of Chongqing
Chongqing, Chongqing Municipality, 402760, China
Conditions
Explore the condition pages connected to this study.